Pharmaceutical Technology Europe-07-01-2009

Pharmaceutical Technology Europe
Biopharmaceuticals

July 01, 2009

Biopharmaceutical companies generally try to avoid paying royalties on novel technologies, including novel expression systems, in part because of the inability to predict revenue flow after a product is commercialized.

Pharmaceutical Technology Europe

Cefaclor is a β-lactam cephalosporin antibiotic that has a wide particle size distribution. Because of the nonporous nature of the material, the specific surface area value accounts for a significant amount of fine particles possibly present in the samples under analysis.

Pharmaceutical Technology Europe

Patents are an important tool for protecting innovative products, uses or processes intended for commercialization.

Pharmaceutical Technology Europe
Business

July 01, 2009

The world's top 50 pharmaceutical companies accounted for prescription drug sales of $558 billion (413 billion euro) in 2008.

Pharmaceutical Technology Europe
Outsourcing review

July 01, 2009

During the past decade, big pharmaceutical companies have been making major efforts to restructure their manufacturing networks. In their haste to shed costs and assets, however, some may be adding risk to their product supply chains.

Pharmaceutical Technology Europe
Information technology

July 01, 2009

Social media is big news. From Facebook to Twitter, individuals are embracing the opportunity to participate in online publishing at an unprecedented rate. Communities of users interact globally, minutetominute within huge databases of content that they themselves create.

Pharmaceutical Technology Europe
Talking Point

July 01, 2009

Are manufacturers ready to deal with the economic and logistical challenges that accompany tailored therapeutics?

Pharmaceutical Technology Europe

You are invited to Link In and Twitter with PTE!

Pharmaceutical Technology Europe
Ask the Expert

July 01, 2009

One of the greatest risks to the success of a business is human error caused by employees' misunderstanding of key aspects of their job roles, and this risk is commonly overlooked or underestimated.

Pharmaceutical Technology Europe

Rare diseases represent an important area of unmet medical need.